Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Pregnancy can cause skin darkening, varicose veins, more sweating, hair growth, hair loss after birth, nail changes, and gum inflammation.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Oral retinoids are effective for various skin conditions but have side effects and should not be used during pregnancy.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Green tea may help with health issues like cancer, heart disease, and weight loss due to its high catechin content.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Trichoscopy is a quick, noninvasive method to diagnose hair and scalp disorders, often reducing the need for biopsies.

Lithium therapy may cause skin problems like hidradenitis suppurativa and other side effects, which can improve after stopping the medication.

The document concludes that accurate diagnosis is crucial for effectively treating common scalp disorders, which often have similar symptoms.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Zinc supplements may be needed to treat hair loss in hypothyroidism.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.